Premier Value Chest And Sinus Congestion Relief
NDC Package 68016-021-01
Package Information
Premier Value Chest And Sinus Congestion Relief is temporarily relieves symptoms associated with a cough ,the common cold,hay fever or other upper respiratory allergies.helps loosen phlegm;mucusclear nasal passagewaysloosens nasal congestiondrain bronchial tubesshrinks swollen membranesclears stuffy nosemakes coughs more productive. Marketed by Chain Drug Consortium, Llc, this product is identified by NDC 68016-021 and is authorized under FDA application part341.
Identification & Billing
- RxCUI: 1304111 - guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet
- RxCUI: 1304111 - guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 68016 - Chain Drug Consortium, Llc
- 68016-021 - Premier Value Chest And Sinus Congestion Relief
- 68016-021-01 - 1 BOTTLE, PLASTIC in 1 CARTON / 50 TABLET in 1 BOTTLE, PLASTIC
- 68016-021 - Premier Value Chest And Sinus Congestion Relief
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 68016-021-01 identifies a specific commercial package of 1 bottle, plastic in 1 carton / 50 tablet in 1 bottle, plastic of Premier Value Chest And Sinus Congestion Relief, labeled by Chain Drug Consortium, Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Consortium, Llc on February 01, 2006. The current certification is valid through December 31, 2018.
How is this Chain Drug Consortium, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 68016002101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.